These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8869476)

  • 1. The economics of immune tolerance and treatment of hemophiliacs with inhibitors.
    Kessler CM; Aledort LM
    Vox Sang; 1996; 70 Suppl 1():74-6. PubMed ID: 8869476
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
    White GC; Greenwood R; Escobar M; Frelinger JA
    Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII inhibitors. Immune tolerance induction: is it cost effective? We know too little.
    Aledort LM
    Semin Thromb Hemost; 2000; 26(2):189-93. PubMed ID: 10919412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor.
    Mariani G; Brackmann HH
    Haematologica; 2001 Mar; 86(3):225-6. PubMed ID: 11255267
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune tolerance therapy for inhibitors in haemophilia A].
    Oldenburg J
    Hamostaseologie; 2008 Oct; 28 Suppl 1():S23-5. PubMed ID: 18958334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitor economics.
    Teitel J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S14-7. PubMed ID: 16690371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tolerance using porcine factor VIII.
    Hay CR; Laurian Y
    Vox Sang; 1996; 70 Suppl 1():68-9. PubMed ID: 8869473
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological and laboratory aspects of immune tolerance.
    Kazatchkine M; Hoyer L
    Vox Sang; 1996; 70 Suppl 1():52-9. PubMed ID: 8869470
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune tolerance in hemophilia and the treatment of hemophiliacs with an inhibitor. Proceedings of a meeting. Palermo, Italy, October 1999.
    Haematologica; 2000 Oct; 85(10 Suppl):1-116. PubMed ID: 11236744
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophilia care in the 21st century.
    Kempton CL; Escobar MA; Roberts HR
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):733-40. PubMed ID: 16170890
    [No Abstract]   [Full Text] [Related]  

  • 12. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

  • 13. Very-high-purity versus intermediate-purity factor VIII in human immunodeficiency virus-positive hemophiliacs: conclusions of a prospective 3-year study. Monoclate Study Group.
    Seremetis SV
    Semin Hematol; 1993 Oct; 30(4 Suppl 5):10-3. PubMed ID: 7903480
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
    Rup B
    Dev Biol (Basel); 2003; 112():55-9. PubMed ID: 12762504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune tolerance in two high responder, severe hemophilia A patients with inhibitors: the importance of high doses and the duration of the treatment.
    Ciavarella N; Schiavoni M; Fasano A; Giliberti MG; Ettorre C; Stefanile C
    Vox Sang; 1996; 70 Suppl 1():72-3. PubMed ID: 8869475
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemophilia treatment. Side effects during immune tolerance induction.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Haematologica; 2000 Oct; 85(10 Suppl):75-7. PubMed ID: 11187878
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of current knowledge to the management of bleeding events during immune tolerance induction.
    Di Paola J; Aledort L; Britton H; Carcao M; Grabowski E; Hutter J; Journeycake J; Kempton C; Leissinger C
    Haemophilia; 2006 Nov; 12(6):591-7. PubMed ID: 17083508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health status in Iranian haemophilic patients.
    Karimi M; Rahmani S; Ardeshiri R; Pasalar M
    Haemophilia; 2008 May; 14(3):615-7. PubMed ID: 18393983
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
    Landolfi R; de Cristofaro R; Lazzareschi I; Riccardi R; Mariani G
    Haematologica; 2000 Oct; 85(10 Suppl):73-4. PubMed ID: 11187877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies of haemophilic patients with inhibitors treated with Factor VIII concentrates in a protocol to induce immunotolerance.
    Aznar JA; Jorquera JI; Carbonell F; Sánchez-Cuenca JM; Trenor A; De Andrés Medina R; Carmona E; González-Molina A
    Thromb Haemost; 1984 Oct; 52(2):212-3. PubMed ID: 6441305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.